Advancing Oncology in Africa: The Potential of PI3K Inhibitors within the Africa United Health Framework

ABOUT AFRICA UNITED
By partnering with innovators like Selleckchem, the initiative gains access to critical research tools, including advanced PI3K inhibitors. These inhibitors are vital in studying the PI3K/AKT/mTOR signaling pathway, which is frequently dysregulated in various diseases. Access to such high-precision biochemicals is essential for African researchers working to develop targeted therapies for cancer and infectious diseases, ensuring that the continent remains at the forefront of molecular medicine.

Nearly one third of deaths among children under five are preventable by vaccine, and millions of African children remain unprotected from life-threatening but preventable health conditions. Africa United is currently being deployed to catalyze popular and political will around universal vaccination use across the continent.